NLRP3 inflammasome amplification across AD and PD proteinopathy

Mechanistic description

Shared mechanism across AD, PD: Misfolded protein stress activates microglial NLRP3; IL-1 beta and inflammasome signaling then amplify amyloid/tau pathology in AD and alpha-synuclein pathology with dopaminergic injury in PD, creating a shared inflammatory feed-forward loop.

Falsifiable prediction: Selective NLRP3 inhibition should reduce ASC speck formation and IL-1 beta release by at least 50%, and secondarily lower tau/alpha-synuclein seeded aggregation by at least 20% in AD and PD co-culture models.

Proposed experiment: Treat APP/PS1-tau microglia-neuron co-cultures and alpha-synuclein PD co-cultures with a selective NLRP3 inhibitor, NLRP3 knockout, and inactive analog; quantify ASC specks, caspase-1, IL-1 beta, p-tau, alpha-synuclein seeds, and neuronal survival.

Cross-disease confidence rationale: Direct AD mouse evidence plus PD alpha-synuclein inflammasome inhibition evidence.

Internal SciDEX support: SciDEX support query found 96 matching hypotheses across 8 disease labels, including 96 with debate_count > 0.

Generated by task ffd81f3a-7f04-4db1-8547-1778ce030e89 as a cross-disease mechanism synthesis, not a single-disease hypothesis renamed as multi-disease.

Mechanism / pathway

NLRP3
→
NLRP3 inflammasome, IL-1 beta, amyloid/tau and alpha-synuclein feed-forward injury
→
multi

Evidence for (9)

NLRP3 is activated in AD and contributes to pathology in APP/PS1 mice.

PMID:23254930 2013
NLRP3 inflammasome activation drives tau pathology.

PMID:31748742 2019
Inflammasome inhibition prevents alpha-synuclein pathology and dopaminergic neurodegeneration.

PMID:30381407 2018
Autophagy-NLRP3 interactions span AD and PD.

PMID:36262883 2023
NLRP3-dependent caspase-1 activation causes maturation and release of IL-1beta from microglia into the extracellular milieu.

PMID:28940479
NLRP3-dependent caspase-1 activation causes maturation and release of IL-1beta from microglia into the extracellular milieu.

PMID:39381137
NLRP3 inflammasome activation in microglia creates a feed-forward loop wherein IL-1beta-induced protein pathology further activates NLRP3, sustaining chronic neuroinflammation.

PMID:31748742
NLRP3 inflammasome activation in microglia creates a feed-forward loop wherein IL-1beta-induced protein pathology further activates NLRP3, sustaining chronic neuroinflammation.

PMID:37917301
NLRP3 inflammasome activation in microglia creates a feed-forward loop wherein IL-1beta-induced protein pathology further activates NLRP3, sustaining chronic neuroinflammation.

PMID:37541353

Evidence against (1)

PMID:34117094 2021

Evidence matrix

9 supporting 0 contradicting

100% supporting

Supporting

NLRP3 is activated in AD and contributes to pathology in APP/PS1 mice. PMID:23254930 · 2013 · 10.1038/nature11729
NLRP3 inflammasome activation drives tau pathology. PMID:31748742 · 2019 · 10.1038/s41586-019-1769-z
Inflammasome inhibition prevents alpha-synuclein pathology and dopaminergic neurodegeneration. PMID:30381407 · 2018 · 10.1126/scitranslmed.aah4066
Autophagy-NLRP3 interactions span AD and PD. PMID:36262883 · 2023 · 10.3389/fnagi.2022.1018848
NLRP3-dependent caspase-1 activation causes maturation and release of IL-1beta from microglia into the extracellular milieu. PMID:28940479
NLRP3-dependent caspase-1 activation causes maturation and release of IL-1beta from microglia into the extracellular milieu. PMID:39381137
NLRP3 inflammasome activation in microglia creates a feed-forward loop wherein IL-1beta-induced protein pathology further activates NLRP3, sustaining chronic neuroinflammation. PMID:31748742
NLRP3 inflammasome activation in microglia creates a feed-forward loop wherein IL-1beta-induced protein pathology further activates NLRP3, sustaining chronic neuroinflammation. PMID:37917301
NLRP3 inflammasome activation in microglia creates a feed-forward loop wherein IL-1beta-induced protein pathology further activates NLRP3, sustaining chronic neuroinflammation. PMID:37541353

Contradicting

No contradicting evidence recorded.

Top-ranked evidence

trust_score × relevance_score × exp(-recency_weight × recency_days / 365)

Supports · top 3

#1 paper-23254930 0.470 trust 0.50 · rel 1.00 · 74d
#2 paper-e3e82982273c 0.470 trust 0.50 · rel 1.00 · 74d
#3 paper-f1d10d698144 0.470 trust 0.50 · rel 1.00 · 74d

4 total ranked · scidex.hypotheses.evidence_ranking

Cite this hypothesis

Citation

etl-backfill (2026). NLRP3 inflammasome amplification across AD and PD proteinopathy. SciDEX hypothesis. https://prism.scidex.ai/hypotheses/h-cross-synth-nlrp3-inflammasome

BibTeX

@misc{scidex_hypothesis_hcrosssy,
  title        = {NLRP3 inflammasome amplification across AD and PD proteinopathy},
  author       = {etl-backfill},
  year         = {2026},
  howpublished = {SciDEX hypothesis},
  url          = {https://prism.scidex.ai/hypotheses/h-cross-synth-nlrp3-inflammasome},
  note         = {SciDEX artifact hypothesis:h-cross-synth-nlrp3-inflammasome}
}